Crispr Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $39M | 593k | 64.82 |
| 2025-03-31 | $10M | 296k | 34.03 |
| 2024-12-31 | $11M | 289k | 39.36 |
| 2024-09-30 | $17M | 354k | 46.98 |
| 2024-06-30 | $18M | 329k | 54.01 |
| 2024-03-31 | $27M | 393k | 68.16 |
| 2023-12-31 | $29M | 463k | 62.60 |
| 2023-09-30 | $24M | 520k | 45.39 |
| 2023-06-30 | $31M | 551k | 56.14 |
| 2023-03-31 | $24M | 539k | 45.15 |
| 2022-12-31 | $24M | 590k | 40.67 |
| 2022-06-30 | $40M | 663k | 60.79 |
| 2022-03-31 | $41M | 647k | 62.78 |
| 2021-12-31 | $59M | 772k | 75.77 |
| 2021-03-31 | $67M | 550k | 121.85 |
| 2020-12-31 | $69M | 452k | 153.11 |
| 2020-09-30 | $35M | 407k | 84.99 |
| 2020-06-30 | $18M | 247k | 73.48 |
| 2020-03-31 | $8.3M | 195k | 42.41 |
| 2019-12-31 | $15M | 239k | 60.98 |
| 2019-09-30 | $188k | 4.6k | 40.92 |
| 2019-06-30 | $6.0M | 132k | 45.47 |
| 2019-03-31 | $151k | 4.2k | 35.84 |
| 2018-12-31 | $1.5M | 52k | 28.62 |
| 2018-09-30 | $14M | 321k | 44.40 |
| 2018-06-30 | $3.1M | 53k | 58.84 |
| 2017-12-31 | $2.5M | 107k | 23.48 |